Among respondents who have used compounding pharmacies, over three-quarters (79%) report having a positive experience. However, only 42% of adults are familiar with pharmacy compounding.
Whitman will leave behind a legacy of commitment to member service and industry leadership.
New 7.5 mg and 10 mg Zepbound single-dose vials now available for $499 per month via Zepbound Self Pay Journey Program.
Emory Healthcare Network is the first clinically integrated network in the country to include MinuteClinic as an in-network primary care provider.
SELARSDI is the second biosimilar to launch in the U.S. under the Teva and Alvotech strategic partnership, which includes nine products.
Walgreens multi-year, $15 million fundraising commitment includes a point-of-sale donation campaign to enhance the lifesaving capacity of the American Heart Association.
Calls made through the app display the practice’s designated office number, maintaining professional boundaries and presenting patients with a number they are likely to recognize and trust.
Jones pointed to the layoffs of 89 staffers in the food division, cuts he called “indiscriminate.”
If approved, Dupixent would be the first and only targeted medicine to treat BP in the US; FDA decision expected by June 20, 2025.
“Our pharmacy business has never been stronger. We continue to grow and fill the needs of our guests,” Tsipakis says.
By Micah Cost, CEO, Pharmacy Quality Alliance (PQA)
By Sandra Hanna, CEO Neighbourhood Pharmacies.
Ana Archbold is responsible for setting and executing the broader strategy for the company’s Self-Care and Wellness division in the U.S.
The AAM warns that IRA price controls may reduce generics and biosimilars, slowing competition and keeping drug prices high.
The senate vote was split nearly along party lines. Industry organizations respond to confirmation.
Walgreens chief executive Officer Tim Wentworth said on an earnings call last month that the company plans to divest VillageMD and use any proceeds to reduce debt and improve its balance sheet.
